What is the equity of Zhejiang Orient Gene Biotech Co this year?
Zhejiang Orient Gene Biotech Co has equity of 7.44 B CNY this year.
Zhejiang Orient Gene Biotech Co Equity 2024
Zhejiang Orient Gene Biotech Co Equity
7.44 B CNY
Ticker
688298.SS
ISIN
CNE100003RM8
In 2024, Zhejiang Orient Gene Biotech Co's equity was 7.44 B CNY, a -8.9% increase from the 8.16 B CNY equity in the previous year.
Zhejiang Orient Gene Biotech Co Aktienanalyse
What does Zhejiang Orient Gene Biotech Co do?
Zhejiang Orient Gene Biotech Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Zhejiang Orient Gene Biotech Co's Equity
Zhejiang Orient Gene Biotech Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Zhejiang Orient Gene Biotech Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Zhejiang Orient Gene Biotech Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Zhejiang Orient Gene Biotech Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Zhejiang Orient Gene Biotech Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Zhejiang Orient Gene Biotech Co Stock
What was the equity of Zhejiang Orient Gene Biotech Co compared to the previous year?
The equity of Zhejiang Orient Gene Biotech Co has increased/decreased by -8.9% decreased compared to the previous year.
What impact does a high equity have on investors of Zhejiang Orient Gene Biotech Co?
A high equity is advantageous for investors of Zhejiang Orient Gene Biotech Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Zhejiang Orient Gene Biotech Co?
A low equity can be a risk for investors of Zhejiang Orient Gene Biotech Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Zhejiang Orient Gene Biotech Co affect the company?
An increase in equity of Zhejiang Orient Gene Biotech Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Zhejiang Orient Gene Biotech Co affect the company?
A reduction in equity of Zhejiang Orient Gene Biotech Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Zhejiang Orient Gene Biotech Co?
Some factors that can affect the equity of Zhejiang Orient Gene Biotech Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Zhejiang Orient Gene Biotech Co so important for investors?
The equity of Zhejiang Orient Gene Biotech Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Zhejiang Orient Gene Biotech Co take to change the equity?
To change equity, Zhejiang Orient Gene Biotech Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Zhejiang Orient Gene Biotech Co pay?
Over the past 12 months, Zhejiang Orient Gene Biotech Co paid a dividend of 1.67 CNY . This corresponds to a dividend yield of about 5.97 %. For the coming 12 months, Zhejiang Orient Gene Biotech Co is expected to pay a dividend of 1.67 CNY.
What is the dividend yield of Zhejiang Orient Gene Biotech Co?
The current dividend yield of Zhejiang Orient Gene Biotech Co is 5.97 %.
When does Zhejiang Orient Gene Biotech Co pay dividends?
Zhejiang Orient Gene Biotech Co pays a quarterly dividend. This is distributed in the months of July, August, July, July.
How secure is the dividend of Zhejiang Orient Gene Biotech Co?
Zhejiang Orient Gene Biotech Co paid dividends every year for the past 4 years.
What is the dividend of Zhejiang Orient Gene Biotech Co?
For the upcoming 12 months, dividends amounting to 1.67 CNY are expected. This corresponds to a dividend yield of 5.97 %.
In which sector is Zhejiang Orient Gene Biotech Co located?
Zhejiang Orient Gene Biotech Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zhejiang Orient Gene Biotech Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zhejiang Orient Gene Biotech Co from 6/26/2023 amounting to 1.667 CNY, you needed to have the stock in your portfolio before the ex-date on 6/26/2023.
When did Zhejiang Orient Gene Biotech Co pay the last dividend?
The last dividend was paid out on 6/26/2023.
What was the dividend of Zhejiang Orient Gene Biotech Co in the year 2023?
In the year 2023, Zhejiang Orient Gene Biotech Co distributed 3.679 CNY as dividends.
In which currency does Zhejiang Orient Gene Biotech Co pay out the dividend?
The dividends of Zhejiang Orient Gene Biotech Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zhejiang Orient Gene Biotech Co
Our stock analysis for Zhejiang Orient Gene Biotech Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zhejiang Orient Gene Biotech Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Zhejiang Orient Gene Biotech Co Revenue
- Zhejiang Orient Gene Biotech Co Net Income
- Zhejiang Orient Gene Biotech Co P/E
- Zhejiang Orient Gene Biotech Co P/S
- Zhejiang Orient Gene Biotech Co EBIT
- Zhejiang Orient Gene Biotech Co Dividend
- Zhejiang Orient Gene Biotech Co Stocks
- Zhejiang Orient Gene Biotech Co Market capitalization
- Zhejiang Orient Gene Biotech Co Debt
- Zhejiang Orient Gene Biotech Co Liabilities
- Zhejiang Orient Gene Biotech Co Equity
- Zhejiang Orient Gene Biotech Co AAQS
- Zhejiang Orient Gene Biotech Co Employees
- Zhejiang Orient Gene Biotech Co ROE
- Zhejiang Orient Gene Biotech Co ROA
- Zhejiang Orient Gene Biotech Co ROCE